NCT01473485View on ClinicalTrials.gov

ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors

NAActive, not recruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

GliomaMetastatic Brain Cancer

Interventions

DEVICE

ExAblate Transcranial System

MR Guided Focused Ultrasound

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors

lead

InSightec

INDUSTRY